Back to search

Article

Different Dosage Regimens of Eptinezumab for the Treatment of Migraine: A Meta-Analysis from Randomized Controlled Trials

2020-11-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Migraine is one of the most common neurological diseases around the world and calcitonin gene-related peptide(CGRP)plays an important role in its pathophysiology. Therefore, in the present study, we evaluated the efficacy of monoclonal antibodies blocking the CGRP ligand or receptor in episodic and chronic migraine. <bold>Objective</bold>The objective of our study...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
285b1337-2638-51b9-8e03-2ce8a2b9ba99
DOI
10.21203/rs.3.rs-108533/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Different Dosage Regimens of Eptinezumab for the Treatment of Migraine: A Meta-Analysis from Randomized Controlled TrialsDOI 10.21203/rs.3.rs-108533/v1
Select a neighboring publication to make it the new centre.